[HTML][HTML] Mass spectrometry-based label-free quantitative proteomics
W Zhu, JW Smith, CM Huang - BioMed research international, 2010 - hindawi.com
In order to study the differential protein expression in complex biological samples, strategies
for rapid, highly reproducible and accurate quantification are necessary. Isotope labeling …
for rapid, highly reproducible and accurate quantification are necessary. Isotope labeling …
Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum …
Colorectal cancer (CRC) is a common cause of cancer-related mortality in the developed
world. Improved methods for early detection and disease management are urgently needed …
world. Improved methods for early detection and disease management are urgently needed …
Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis
X Zou, B Feng, T Dong, G Yan, B Tan, H Shen… - Journal of …, 2013 - Elsevier
Colorectal cancer (CRC) is one of the most prevalent cancers worldwide. The discovery of
non-invasive biomarker candidates for diagnosis and prognosis is important for the …
non-invasive biomarker candidates for diagnosis and prognosis is important for the …
[HTML][HTML] Discovery and pharmacological evaluation of STEAP4 as a novel target for HER2 overexpressing breast cancer
IM Orfanou, O Argyros, A Papapetropoulos… - Frontiers in …, 2021 - frontiersin.org
Breast cancer (BC) is a highly heterogeneous disease encompassing multiple subtypes with
different molecular and histopathological features, disease prognosis, and therapeutic …
different molecular and histopathological features, disease prognosis, and therapeutic …
Mass spectrometry of peptides and proteins from human blood
It is difficult to convey the accelerating rate and growing importance of mass spectrometry
applications to human blood proteins and peptides. Mass spectrometry can rapidly detect …
applications to human blood proteins and peptides. Mass spectrometry can rapidly detect …
Label-free mass spectrometry-based proteomics for biomarker discovery and validation
TV Pham, SR Piersma, G Oudgenoeg… - Expert review of …, 2012 - Taylor & Francis
For most diseases, better biomarkers are urgently needed to enable (early) detection,
diagnosis, prognosis, stratification for therapy and response monitoring. Proteomics …
diagnosis, prognosis, stratification for therapy and response monitoring. Proteomics …
Evolution of clinical proteomics and its role in medicine
E Boja, T Hiltke, R Rivers, C Kinsinger… - Journal of Proteome …, 2011 - ACS Publications
Significant progress has been made in characterizing and sequencing genomic alterations
of biospecimens from several types of cancer. Understanding the functional changes in the …
of biospecimens from several types of cancer. Understanding the functional changes in the …
[HTML][HTML] Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma
Multiple myeloma (MM) is the second most common hematological malignancy in adults. It is
characterized by clonal proliferation of terminally differentiated B lymphocytes and over …
characterized by clonal proliferation of terminally differentiated B lymphocytes and over …
Quantitative mass spectrometry for colorectal cancer proteomics
J Martínez‐Aguilar, J Chik, J Nicholson… - PROTEOMICS …, 2013 - Wiley Online Library
This review documents the uses of quantitative MS applied to colorectal cancer (CRC)
proteomics for biomarker discovery and molecular pathway profiling. Investigators are …
proteomics for biomarker discovery and molecular pathway profiling. Investigators are …
In silico analysis validates proteomic findings of formalin-fixed paraffin embedded cutaneous squamous cell carcinoma tissue
A Azimi, KL Kaufman, M Ali, S Kossard… - Cancer genomics & …, 2016 - cgp.iiarjournals.org
Background: Cutaneous squamous cell carcinoma (cSCC) is a common type of skin cancer
but there are no comprehensive proteomic studies on this entity. Materials and Methods: We …
but there are no comprehensive proteomic studies on this entity. Materials and Methods: We …